MedAlliance announces first patient enrolled in the 3,300 Patient Landmark Sirolimus DEB vs DES Study

Sep 01, 2021

Geneva [Switzerland], September 1 (ANI/PRNewswire): MedAlliance is pleased to announce the enrollment of the first patient in the ground-breaking coronary randomized controlled study "SELUTION...

MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study

Sep 15, 2023

Geneva [Switzerland], September 15: MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now half...

Over 1,000 patients enrolled in Landmark SELUTION DeNovo Study

Mar 15, 2023

Geneva [Switzerland], March 15 (ANI/PRNewswire): MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now...

First patient enrolled in SELUTION SLR IDE BTK Study

Jun 08, 2022

Leipzig [Germany], June 8 (ANI/PRNewswire): The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial involving SELUTION SLR™, MedAlliance's...

First US patient enrolled in SELUTION SLR IDE Peripheral Study

Aug 24, 2022

Geneva [Switzerland], August 24 (ANI/PRNewswire): The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR™, MedAlliance's novel...

First patient enrolled in SELUTION SLR™ SUCCESS PTA study

Feb 11, 2021

Nyon [Switzerland], February 11 (ANI/PRNewswire): MedAlliance has announced enrolment of the first patient in SUCCESS PTA, its large post-market study with the drug-eluting balloon...